QA: Optinose Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001494650_2024_Optinose_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001494650, Optinose Inc

  xvar xval
0 AssetsCurrent 105,333,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 815,000
3 remainder_Assets 1,581,000
4 LiabilitiesCurrent 176,524,000
5 LiabilitiesNoncurrent 611,000
6 remainder_Liabilities 17,200,000
7 CostOfGoodsAndServicesSold 7,198,487
8 SellingGeneralAndAdministrativeExpense 53,324,462
9 ResearchAndDevelopmentExpense 6,445,566
10 remainder_Expenses 14,684,583
11 remainder_Revenues 65,819,606
12 remainder_NetIncome 1,114,313
13 remainder_ComprehensiveNetIncome -1,351
  yvar yval
0 Assets 107,729,000
1 Liabilities 194,335,000
2 Expenses 81,653,098
3 Revenues 65,819,606
4 StockholdersEquity -86,606,000
5 NetIncome -14,719,179
6 ComprehensiveNetIncome -14,719,854
7 BaseVar 225,326,184
8 EconomicCapitalRatiobeforeLimitedLiability -1.35
9 EconomicCapitalRatio 1.22

Edgar->Model Mapping

Feature Distribution

Change over Time